High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.
- Citation:
- Leuk Lymphoma vol 49 (6) 1202-5
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Raymond Lai Nancy L Bartlett John R Mackey Sin-Ho Jung Jeffrey L Johnson James R Cook Dan Jones Carol E Cass James D Young Jonathan Said Bruce Cheson Eric D Hsi
- Networks:
- Study
- CALGB-59804
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords:
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Deoxycytidine, Doxorubicin, Equilibrative Nucleoside Transporter 1, Female, Hodgkin Disease, Humans, Liposomes, Male, Middle Aged, Neoplasm Recurrence, Local, Reed-Sternberg Cells, Survival Rate, Treatment Failure, Vinblastine